Edison Expands its Asia-Pac Pharmaceutical Presence with Launch of Coverage of Mesoblast

Mesoblast's pipeline is based on its proprietary mesenchymal precursor cell and culture-expanded mesenchymal stem cell technologies.

http://www.hispanicbusiness.com/2013/11/27/edison_expands_its_asia-pac_pharmaceutical_presence.htm